SCHEMBL26299730

SCHEMBL26299730

CC(C)C(c1ccc(C(F)(F)F)cc1)C(C)C

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 4/20 0.50
▸ HDAC1 Q13547 1/20 0.44
▸ HDAC8 Q9BY41 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44
▸ CES2 O00748 2/20 0.42
▸ CES1 P23141 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.40
▸ ACP3 P15309 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ KIF11 P52732 5/20 0.39
▸ AKR1C3 P42330 1/20 0.39
▸ AKR1C2 P52895 1/20 0.39
▸ ORAI1 Q96D31 1/20 0.38
▸ ORAI2 Q96SN7 1/20 0.38
▸ ORAI3 Q9BRQ5 1/20 0.38
▸ TRPV6 Q9H1D0 1/20 0.38
▸ MGLL Q99685 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13328621 0.81 PDE2A (0.50) PDE2ACES2CES1ALDH1A1ACP3
SCHEMBL12086293 0.81 PDE2A (0.50) PDE2ACES2CES1ALDH1A1ACP3
SCHEMBL25502574 0.81 PDE2A (0.50) PDE2ACES2CES1ALDH1A1ACP3
SCHEMBL84043 0.80 PDE2A (0.53) PDE2ACES2CES1ALDH1A1ACP3
SCHEMBL16230724 0.79 PDE2A (0.48) PDE2ACES2CES1ALDH1A1ACP3
SCHEMBL19772091 0.79 PDE2A (0.48) PDE2ACES2CES1ALDH1A1ACP3
SCHEMBL19772099 0.79 PDE2A (0.48) PDE2ACES2CES1ALDH1A1ACP3
SCHEMBL27480614 0.79 PDE2A (0.44) PDE2ACES2CES1ALDH1A1ACP3
SCHEMBL18698639 0.79 NR1H2 (0.53) HDAC1HDAC8HDAC6
SCHEMBL7438101 0.78 PDE2A (0.52) PDE2ACES2CES1ALDH1A1ACP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023165263-A1 PYRROLOTRIAZINONE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, PREPARATION METHOD THEREFOR, AND USE THEREOF 上海科技大学 2023-09-07 — — WO disclosed
Send feedback